563 related articles for article (PubMed ID: 21840694)
1. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
Ju CR; Chen RC
Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
[TBL] [Abstract][Full Text] [Related]
2. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
3. [Serum myostatin levels and malnutrition in patients with chronic obstructive pulmonary disease].
Ju CR; Chen RC
Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):465-8. PubMed ID: 21781527
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting.
Zhou G; Gui X; Chen R; Fu X; Ji X; Ding H
Clinics (Sao Paulo); 2019; 74():e981. PubMed ID: 31271588
[TBL] [Abstract][Full Text] [Related]
5. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
6. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
[TBL] [Abstract][Full Text] [Related]
7. [Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease].
Peng M; Cai BQ; Ma Y; Zhu HJ; Sun Q; Song AL
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):182-5. PubMed ID: 17572996
[TBL] [Abstract][Full Text] [Related]
8. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
Yang YM; Sun TY; Liu XM
Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
[TBL] [Abstract][Full Text] [Related]
9. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
[TBL] [Abstract][Full Text] [Related]
10. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
[TBL] [Abstract][Full Text] [Related]
11. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD.
Remels AH; Schrauwen P; Broekhuizen R; Willems J; Kersten S; Gosker HR; Schols AM
Eur Respir J; 2007 Aug; 30(2):245-52. PubMed ID: 17459894
[TBL] [Abstract][Full Text] [Related]
13. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
14. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.
Plant PJ; Brooks D; Faughnan M; Bayley T; Bain J; Singer L; Correa J; Pearce D; Binnie M; Batt J
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):461-71. PubMed ID: 19520920
[TBL] [Abstract][Full Text] [Related]
15. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
16. The effects of cachexia and related components on pulmonary functions in patients with COPD.
Görek Dilektaşli A; Ulubay G; Bayraktar N; Eminsoy I; Oner Eyüboğlu F
Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469
[TBL] [Abstract][Full Text] [Related]
17. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
[TBL] [Abstract][Full Text] [Related]
18. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
19. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
20. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
